Rapid Dose Therapeutics Corp. (DOSE.CN)
CAD 0.23
(-4.17%)
CAD 0.23
(-4.17%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.02 Million | 718.29 Thousand | 1.75 Million | 262.8 Thousand | 101.49 Thousand | - |
| Cost of Revenue | 457.01 Thousand | 345.89 Thousand | 407.11 Thousand | 55.35 Thousand | 64.16 Thousand | 156.27 Thousand |
| Gross Profit | 563.4 Thousand | 372.4 Thousand | 1.34 Million | 207.45 Thousand | 37.33 Thousand | -156.27 Thousand |
| Operating Expenses | 4.2 Million | 3.91 Million | 5.64 Million | 2.33 Million | 7.54 Million | 3.11 Million |
| Selling, General and Administrative Expenses | 2.59 Million | 3.18 Million | 4.38 Million | 1.5 Million | 6.78 Million | 2.89 Million |
| Research and Development Expenses | 427.79 Thousand | 92.88 Thousand | 359.29 Thousand | 85.31 Thousand | 272.71 Thousand | 222.35 Thousand |
| Other Expenses | - | 643.06 Thousand | 902.22 Thousand | 745.46 Thousand | 484.05 Thousand | 156.27 Thousand |
| Cost and Expenses | 4.66 Million | 4.26 Million | 6.05 Million | 2.38 Million | 7.6 Million | 3.27 Million |
| Operating Income | -3.73 Million | -3.54 Million | -4.3 Million | -2.12 Million | -7.5 Million | -3.27 Million |
| Interest Expense | 661.45 Thousand | 264.64 Thousand | 133.48 Thousand | 142.56 Thousand | 108.51 Thousand | 201.00 |
| Income Tax Expense | - | 1610.00 | 4.06 Million | 142.56 Thousand | 199.24 Thousand | 3.00 |
| Earnings before Tax | -4.3 Million | -3.81 Million | -8.48 Million | -2.29 Million | -7.96 Million | -11.39 Million |
| Net Income | -4.3 Million | -3.81 Million | -12.54 Million | -2.44 Million | -8.16 Million | -11.39 Million |
| Earnings Per Share Basic | -0.04 | -0.04 | -0.13 | -0.03 | -0.11 | -0.18 |
| Earnings Per Share Diluted | -0.04 | -0.04 | -0.13 | -0.03 | -0.11 | -0.18 |
| Weighted Average Shares Outstanding | 104.96 Million | 103.41 Million | 100.21 Million | 77.78 Million | 76.09 Million | 62.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.96 Million | 103.41 Million | 100.21 Million | 77.78 Million | 76.09 Million | 62.74 Million |
| Gross Margin | 0.55 | 0.52 | 0.77 | 0.79 | 0.37 | - |
| EBIT Margin | -2.96 | -4.06 | -2.01 | -5.52 | -68.11 | - |
| Profit Margin | -4.22 | -5.31 | -7.16 | -9.29 | -80.43 | - |
| EBITDA | -3.02 Million | -2.91 Million | -7.58 Million | -987.22 Thousand | -7.37 Million | -11.24 Million |
| Earnings Before Tax Margin | -3.66 | -4.93 | -2.46 | -8.09 | -73.95 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 515.91 Thousand | 398.99 Thousand | 192.65 Thousand | 1.02 Million | 233.81 Thousand | 353.17 Thousand |
| Cost of Revenue | 831.94 Thousand | 1 Million | 455.32 Thousand | 2.43 Million | 683.95 Thousand | 109.22 Thousand |
| Gross Profit | -316.02 Thousand | -609.69 Thousand | -262.67 Thousand | -1.41 Million | -450.14 Thousand | 243.94 Thousand |
| Operating Expenses | 541.48 Thousand | 344.55 Thousand | 898.27 Thousand | 1.67 Million | 428.34 Thousand | 800.34 Thousand |
| Selling, General and Administrative Expenses | 515.47 Thousand | 315.03 Thousand | 594.86 Thousand | - | 327.97 Thousand | 626.09 Thousand |
| Research and Development Expenses | 26.01 Thousand | 29.51 Thousand | 303.41 Thousand | - | 100.36 Thousand | 1941.00 |
| Other Expenses | - | 82.73 Thousand | - | - | - | -32.12 Thousand |
| Cost and Expenses | 1.37 Million | 1.35 Million | 1.35 Million | 4.1 Million | 1.11 Million | 909.57 Thousand |
| Operating Income | -857.51 Thousand | -954.25 Thousand | -1.16 Million | -3.08 Million | -878.49 Thousand | -556.4 Thousand |
| Interest Expense | 242.14 Thousand | 304.03 Thousand | 304.94 Thousand | 661.45 Thousand | 102.59 Thousand | - |
| Income Tax Expense | - | -3.00 | -4.00 | 452.41 Thousand | 3.00 | 18.1 Thousand |
| Earnings before Tax | -1.09 Million | -1.25 Million | -2.05 Million | -4.3 Million | -981.07 Thousand | -730.68 Thousand |
| Net Income | -1.09 Million | -1.25 Million | -2.05 Million | -4.3 Million | -981.07 Thousand | -730.68 Thousand |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.02 | - | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.02 | - | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 123.11 Million | 121.76 Million | 117.81 Million | 104.96 Million | 103.88 Million | 103.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 123.11 Million | 121.76 Million | 117.81 Million | 104.96 Million | 103.88 Million | 103.41 Million |
| Gross Margin | -0.61 | -1.53 | -1.36 | -1.38 | -1.93 | 0.69 |
| EBIT Margin | -1.56 | -2.18 | -5.09 | - | -3.10 | -1.18 |
| Profit Margin | -2.13 | -3.15 | -10.66 | -4.22 | -4.20 | -2.07 |
| EBITDA | -807.29 Thousand | -871.52 Thousand | -980.17 Thousand | - | -725.65 Thousand | -416.21 Thousand |
| Earnings Before Tax Margin | -1.66 | -2.39 | -6.03 | -3.02 | -3.76 | -1.58 |
2065
9850
LSXMK
1416
APTECHT
603901